世界の増殖性糖尿病性網膜症治療市場 2021：企業別、地域別、種類・用途別

• 英文タイトル：Global Proliferative Diabetic Retinopathy Therapeutics Market 2021 by Company, Regions, Type and Application, Forecast to 2026

• レポートコード：GIR-107A12618 • 出版社/出版日：GlobalInfoResearch / 2021年7月 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、84ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療

• 販売価格（消費税別）

Single User	￥515,040 (USD3,480)	▷ お問い合わせ
Multi User	￥772,560 (USD5,220)	▷ お問い合わせ
Corporate User	￥1,030,080 (USD6,960)	▷ お問い合わせ

• ご注文方法：お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法：銀行振込（納品後、ご請求書送付）

---

レポート概要

---

当調査資料では、増殖性糖尿病性網膜症治療のグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。増殖性糖尿病性網膜症治療の種類別市場規模（オクリプラスミン、PAN-90806、RBM-008、乳酸スクアラミン、THR-687、その他）、用途別市場規模（病院、クリニック、在宅ケア）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・増殖性糖尿病性網膜症治療の市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：Acucela Inc、Aerie Pharmaceuticals Inc、Antisense Therapeutics Ltd、Icon Bioscience Inc、Ohr Pharmaceutical Inc、PanOptica Inc、Ribomic Inc、ThromboGenics NV ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：オクリプラスミン、PAN-90806、RBM-008、乳酸スクアラミン、THR-687、その他 ・用途別分析2016年-2026年：病院、クリニック、在宅ケア ・増殖性糖尿病性網膜症治療の北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・増殖性糖尿病性網膜症治療のヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・増殖性糖尿病性網膜症治療のアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・増殖性糖尿病性網膜症治療の南米市場規模2016年-2026年：ブラジル、アルゼンチン ・増殖性糖尿病性網膜症治療の中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論

The Proliferative Diabetic Retinopathy Therapeutics market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.

According to our latest research, the global Proliferative Diabetic Retinopathy Therapeutics size is estimated to be USD xx million in 2026 from USD xx million in 2020, with a change XX% between 2020 and 2021. The global Proliferative Diabetic Retinopathy Therapeutics market size is expected to grow at a CAGR of xx% for the next five years.

Market segmentation
Proliferative Diabetic Retinopathy Therapeutics market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for revenue by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.

Market segment by Type, covers
Ocriplasmin
PAN-90806
RBM-008
Squalamine Lactate
THR-687
Others

Market segment by Application, can be divided into
Hospital
Clinic
Home Care

Market segment by players, this report covers
Acucela Inc
Aerie Pharmaceuticals Inc
Antisense Therapeutics Ltd
Icon Bioscience Inc
Ohr Pharmaceutical Inc
PanOptica Inc
Ribomic Inc
ThromboGenics NV

Market segment by regions, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, UK, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia, and Rest of Asia-Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)

The content of the study subjects, includes a total of 12 chapters:
Chapter 1, to describe Proliferative Diabetic Retinopathy Therapeutics product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top players of Proliferative Diabetic Retinopathy Therapeutics, with revenue, gross margin and global market share of Proliferative Diabetic Retinopathy Therapeutics from 2019 to 2021.
Chapter 3, the Proliferative Diabetic Retinopathy Therapeutics competitive situation, revenue and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by type and application, with revenue and growth rate by type, application, from 2016 to 2026.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2016 to 2021.and Proliferative Diabetic Retinopathy Therapeutics market forecast, by regions, type and application, with revenue, from 2021 to 2026.
Chapter 11 and 12, to describe Proliferative Diabetic Retinopathy Therapeutics research findings and conclusion, appendix and data source.

レポート目次

---

1 Market Overview
1.1 Product Overview and Scope of Proliferative Diabetic Retinopathy Therapeutics
1.2 Classification of Proliferative Diabetic Retinopathy Therapeutics by Type
1.2.1 Overview: Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Type: 2020 Versus 2021 Versus 2026
1.2.2 Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type in 2020
1.2.3 Ocriplasmin
1.2.4 PAN-90806
1.2.5 RBM-008
1.2.6 Squalamine Lactate
1.2.7 THR-687
1.2.8 Others
1.3 Global Proliferative Diabetic Retinopathy Therapeutics Market by Application
1.3.1 Overview: Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Application: 2020 Versus 2021 Versus 2026
1.3.2 Hospital
1.3.3 Clinic
1.3.4 Home Care
1.4 Global Proliferative Diabetic Retinopathy Therapeutics Market Size & Forecast
1.5 Global Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast by Region
1.5.1 Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region: 2016 VS 2021 VS 2026
1.5.2 Global Proliferative Diabetic Retinopathy Therapeutics Market Size by Region, (2016-2021)
1.5.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size and Prospect (2016-2026)
1.5.4 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size and Prospect (2016-2026)
1.5.5 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size and Prospect (2016-2026)
1.5.6 South America Proliferative Diabetic Retinopathy Therapeutics Market Size and Prospect (2016-2026)
1.5.7 Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Market Size and Prospect (2016-2026)
1.6 Market Drivers, Restraints and Trends
1.6.1 Proliferative Diabetic Retinopathy Therapeutics Market Drivers
1.6.2 Proliferative Diabetic Retinopathy Therapeutics Market Restraints
1.6.3 Proliferative Diabetic Retinopathy Therapeutics Trends Analysis
2 Company Profiles
2.1 Acucela Inc
2.1.1 Acucela Inc Details
2.1.2 Acucela Inc Major Business
2.1.3 Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.1.4 Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.1.5 Acucela Inc Recent Developments and Future Plans
2.2 Aerie Pharmaceuticals Inc
2.2.1 Aerie Pharmaceuticals Inc Details
2.2.2 Aerie Pharmaceuticals Inc Major Business
2.2.3 Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.2.4 Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.2.5 Aerie Pharmaceuticals Inc Recent Developments and Future Plans
2.3 Antisense Therapeutics Ltd
2.3.1 Antisense Therapeutics Ltd Details
2.3.2 Antisense Therapeutics Ltd Major Business
2.3.3 Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.3.4 Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.3.5 Antisense Therapeutics Ltd Recent Developments and Future Plans
2.4 Icon Bioscience Inc
2.4.1 Icon Bioscience Inc Details
2.4.2 Icon Bioscience Inc Major Business
2.4.3 Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.4.4 Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.4.5 Icon Bioscience Inc Recent Developments and Future Plans
2.5 Ohr Pharmaceutical Inc
2.5.1 Ohr Pharmaceutical Inc Details
2.5.2 Ohr Pharmaceutical Inc Major Business
2.5.3 Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.5.4 Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.5.5 Ohr Pharmaceutical Inc Recent Developments and Future Plans
2.6 PanOptica Inc
2.6.1 PanOptica Inc Details
2.6.2 PanOptica Inc Major Business
2.6.3 PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.6.4 PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.6.5 PanOptica Inc Recent Developments and Future Plans
2.7 Ribomic Inc
2.7.1 Ribomic Inc Details
2.7.2 Ribomic Inc Major Business
2.7.3 Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.7.4 Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.7.5 Ribomic Inc Recent Developments and Future Plans
2.8 ThromboGenics NV
2.8.1 ThromboGenics NV Details
2.8.2 ThromboGenics NV Major Business
2.8.3 ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
2.8.4 ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Revenue, Gross Margin and Market Share (2019-2021)
2.8.5 ThromboGenics NV Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Proliferative Diabetic Retinopathy Therapeutics Revenue and Share by Players (2019-2021)
3.2 Market Concentration Rate
3.2.1 Top 3 Proliferative Diabetic Retinopathy Therapeutics Players Market Share
3.2.2 Top 10 Proliferative Diabetic Retinopathy Therapeutics Players Market Share
3.2.3 Market Competition Trend
3.3 Proliferative Diabetic Retinopathy Therapeutics Players Head Office, Products and Services Provided
3.4 Mergers & Acquisitions
3.5 New Entrants and Expansion Plans
4 Market Size Segment by Type
4.1 Global Proliferative Diabetic Retinopathy Therapeutics Revenue and Market Share by Type (2016-2021)
4.2 Global Proliferative Diabetic Retinopathy Therapeutics Market Forecast by Type (2021-2026)
5 Market Size Segment by Application
5.1 Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application (2016-2021)
5.2 Proliferative Diabetic Retinopathy Therapeutics Market Forecast by Application (2021-2026)
6 North America by Country, by Type, and by Application
6.1 North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2026)
6.2 North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2026)
6.3 North America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
6.3.1 North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2026)
6.3.2 United States Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
6.3.3 Canada Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
6.3.4 Mexico Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
7 Europe by Country, by Type, and by Application
7.1 Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2026)
7.2 Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2026)
7.3 Europe Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
7.3.1 Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2026)
7.3.2 Germany Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
7.3.3 France Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
7.3.4 United Kingdom Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
7.3.5 Russia Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
7.3.6 Italy Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8 Asia-Pacific by Region, by Type, and by Application
8.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2026)
8.2 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2026)
8.3 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Market Size by Region
8.3.1 Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Region (2016-2026)
8.3.2 China Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8.3.3 Japan Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8.3.4 South Korea Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8.3.5 India Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8.3.6 Southeast Asia Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
8.3.7 Australia Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
9 South America by Country, by Type, and by Application
9.1 South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2026)
9.2 South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2026)
9.3 South America Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
9.3.1 South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2026)
9.3.2 Brazil Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
9.3.3 Argentina Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
10 Middle East & Africa by Country, by Type, and by Application
10.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2026)
10.2 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2026)
10.3 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Market Size by Country
10.3.1 Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2026)
10.3.2 Turkey Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
10.3.3 Saudi Arabia Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
10.3.4 UAE Proliferative Diabetic Retinopathy Therapeutics Market Size and Forecast (2016-2026)
11 Research Findings and Conclusion
12 Appendix
12.1 Methodology
12.2 Research Process and Data Source
12.3 Disclaimer

List of Tables
Table 1. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Type, (USD Million), 2020 VS 2021 VS 2026
Table 2. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Application, (USD Million), 2020 VS 2021 VS 2026
Table 3. Global Market Proliferative Diabetic Retinopathy Therapeutics Revenue (Million USD) Comparison by Region (2016 VS 2021 VS 2026)
Table 4. Global Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) by Region (2016-2021)
Table 5. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Region (2021-2026)
Table 6. Acucela Inc Corporate Information, Head Office, and Major Competitors
Table 7. Acucela Inc Major Business
Table 8. Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 9. Acucela Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 10. Aerie Pharmaceuticals Inc Corporate Information, Head Office, and Major Competitors
Table 11. Aerie Pharmaceuticals Inc Major Business
Table 12. Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 13. Aerie Pharmaceuticals Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 14. Antisense Therapeutics Ltd Corporate Information, Head Office, and Major Competitors
Table 15. Antisense Therapeutics Ltd Major Business
Table 16. Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 17. Antisense Therapeutics Ltd Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 18. Icon Bioscience Inc Corporate Information, Head Office, and Major Competitors
Table 19. Icon Bioscience Inc Major Business
Table 20. Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 21. Icon Bioscience Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 22. Ohr Pharmaceutical Inc Corporate Information, Head Office, and Major Competitors
Table 23. Ohr Pharmaceutical Inc Major Business
Table 24. Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 25. Ohr Pharmaceutical Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 26. PanOptica Inc Corporate Information, Head Office, and Major Competitors
Table 27. PanOptica Inc Major Business
Table 28. PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 29. PanOptica Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 30. Ribomic Inc Corporate Information, Head Office, and Major Competitors
Table 31. Ribomic Inc Major Business
Table 32. Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 33. Ribomic Inc Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 34. ThromboGenics NV Corporate Information, Head Office, and Major Competitors
Table 35. ThromboGenics NV Major Business
Table 36. ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Product and Solutions
Table 37. ThromboGenics NV Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million), Gross Margin and Market Share (2019-2021)
Table 38. Global Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) by Players (2019-2021)
Table 39. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Players (2019-2021)
Table 40. Breakdown of Proliferative Diabetic Retinopathy Therapeutics by Company Type (Tier 1, Tier 2 and Tier 3)
Table 41. Proliferative Diabetic Retinopathy Therapeutics Players Head Office, Products and Services Provided
Table 42. Proliferative Diabetic Retinopathy Therapeutics Mergers & Acquisitions in the Past Five Years
Table 43. Proliferative Diabetic Retinopathy Therapeutics New Entrants and Expansion Plans
Table 44. Global Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) by Type (2016-2021)
Table 45. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Type (2016-2021)
Table 46. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Forecast by Type (2021-2026)
Table 47. Global Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021)
Table 48. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Forecast by Application (2021-2026)
Table 49. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 50. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 51. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 52. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 53. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 54. North America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 55. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 56. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 57. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 58. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 59. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 60. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 61. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 62. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 63. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 64. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 65. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Region (2016-2021) & (USD Million)
Table 66. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue by Region (2021-2026) & (USD Million)
Table 67. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 68. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 69. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 70. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 71. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 72. South America Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2021-2026) & (USD Million)
Table 73. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2016-2021) & (USD Million)
Table 74. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Type (2021-2026) & (USD Million)
Table 75. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2016-2021) & (USD Million)
Table 76. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Application (2021-2026) & (USD Million)
Table 77. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2016-2021) & (USD Million)
Table 78. Middle East & Africa Proliferative Diabetic Retinopathy Therapeutics Revenue by Country (2021-2026) & (USD Million)
List of Figures
Figure 1. Proliferative Diabetic Retinopathy Therapeutics Picture
Figure 2. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Type in 2020
Figure 3. Ocriplasmin
Figure 4. PAN-90806
Figure 5. RBM-008
Figure 6. Squalamine Lactate
Figure 7. THR-687
Figure 8. Others
Figure 9. Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Application in 2020
Figure 10. Hospital Picture
Figure 11. Clinic Picture
Figure 12. Home Care Picture
Figure 13. Global Proliferative Diabetic Retinopathy Therapeutics Revenue, (USD Million): 2020 VS 2021 VS 2026
Figure 14. Global Proliferative Diabetic Retinopathy Therapeutics Revenue and Forecast (2016-2026) & (USD Million)
Figure 15. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Region (2016-2026)
Figure 16. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Region in 2020
Figure 17. North America Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 18. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 19. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 20. South America Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 21. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Revenue (USD Million) and Growth Rate (2016-2026)
Figure 22. Proliferative Diabetic Retinopathy Therapeutics Market Drivers
Figure 23. Proliferative Diabetic Retinopathy Therapeutics Market Restraints
Figure 24. Proliferative Diabetic Retinopathy Therapeutics Market Trends
Figure 25. Acucela Inc Recent Developments and Future Plans
Figure 26. Aerie Pharmaceuticals Inc Recent Developments and Future Plans
Figure 27. Antisense Therapeutics Ltd Recent Developments and Future Plans
Figure 28. Icon Bioscience Inc Recent Developments and Future Plans
Figure 29. Ohr Pharmaceutical Inc Recent Developments and Future Plans
Figure 30. PanOptica Inc Recent Developments and Future Plans
Figure 31. Ribomic Inc Recent Developments and Future Plans
Figure 32. ThromboGenics NV Recent Developments and Future Plans
Figure 33. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Players in 2020
Figure 34. Proliferative Diabetic Retinopathy Therapeutics Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
Figure 35. Global Top 3 Players Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share in 2020
Figure 36. Global Top 10 Players Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share in 2020
Figure 37. Key Players Market Share Trend (Top 3 Market Share: 2019 VS 2020 VS 2021)
Figure 38. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Type in 2020
Figure 39. Global Proliferative Diabetic Retinopathy Therapeutics Market Share Forecast by Type (2021-2026)
Figure 40. Global Proliferative Diabetic Retinopathy Therapeutics Revenue Share by Application in 2020
Figure 41. Global Proliferative Diabetic Retinopathy Therapeutics Market Share Forecast by Application (2021-2026)
Figure 42. North America Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Type (2016-2026)
Figure 43. North America Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Application (2016-2026)
Figure 44. North America Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Country (2016-2026)
Figure 45. United States Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 46. Canada Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 47. Mexico Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 48. Europe Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Type (2016-2026)
Figure 49. Europe Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Application (2016-2026)
Figure 50. Europe Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Country (2016-2026)
Figure 51. Germany Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 52. France Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 53. United Kingdom Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 54. Russia Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 55. Italy Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 56. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Type (2016-2026)
Figure 57. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Application (2016-2026)
Figure 58. Asia-Pacific Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Region (2016-2026)
Figure 59. China Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 60. Japan Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 61. South Korea Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 62. India Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 63. Southeast Asia Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 64. Australia Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 65. South America Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Type (2016-2026)
Figure 66. South America Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Application (2016-2026)
Figure 67. South America Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Country (2016-2026)
Figure 68. Brazil Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 69. Argentina Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 70. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Type (2016-2026)
Figure 71. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Sales Market Share by Application (2016-2026)
Figure 72. Middle East and Africa Proliferative Diabetic Retinopathy Therapeutics Revenue Market Share by Country (2016-2026)
Figure 73. Turkey Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 74. Saudi Arabia Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 75. UAE Proliferative Diabetic Retinopathy Therapeutics Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 76. Methodology
Figure 77. Research Process and Data Source

---